HIV Clinical Trials in Birmingham, Alabama
15 recruitingBirmingham, Alabama
Showing 1–15 of 15 trials
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 1
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
HIV
National Institute of Allergy and Infectious Diseases (NIAID)83 enrolled12 locationsNCT07390955
Recruiting
Phase 4
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
Immune DysregulationHIVSystemic Inflammation+1 more
University of Alabama at Birmingham100 enrolled1 locationNCT06829238
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Not Applicable
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
HIV Seropositivity
University of Chicago900 enrolled7 locationsNCT05723653
Recruiting
Phase 2
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
HIV
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled22 locationsNCT06812494
Recruiting
Not Applicable
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
HIVHIV TreatmentHIV Testing+1 more
University of Alabama at Birmingham80 enrolled1 locationNCT05384145
Recruiting
Phase 2
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Mild Neurocognitive DisorderMajor Depressive DisorderHIV
National Institute of Allergy and Infectious Diseases (NIAID)186 enrolled40 locationsNCT06705478
Recruiting
Phase 2
Improving Physical Ability and Cellular Senescence Elimination in HIV
FrailtyHIVAging Problems+1 more
National Institute of Allergy and Infectious Diseases (NIAID)80 enrolled27 locationsNCT07144293
Recruiting
Not Applicable
PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
HIVHIV PreventionPrEP+1 more
University of Alabama at Birmingham56 enrolled1 locationNCT07231640
Recruiting
Not Applicable
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
HypertensionHIV
University of Alabama at Birmingham50 enrolled1 locationNCT07025109
Recruiting
Not Applicable
Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV
Cognitive ImpairmentHIV Infections
University of Alabama at Birmingham110 enrolled3 locationsNCT06013579
Recruiting
Not Applicable
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
Arterial StiffnessCognitive DysfunctionHIV
University of Alabama at Birmingham60 enrolled1 locationNCT05965518
Recruiting
Phase 4
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
HIV
Yale University250 enrolled2 locationsNCT05547048